Propranolol for Treatment of Cocaine Addiction - 2

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status and phase

Completed
Phase 2

Conditions

Cocaine-Related Disorders

Treatments

Drug: Propranolol

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00000197
K20DA000238 (U.S. NIH Grant/Contract)
NIDA-00238-2

Details and patient eligibility

About

The purpose of this study is to evaluate the safety and efficacy of propanolol in the early treatment of cocaine dependence.

Sex

All

Ages

25 to 49 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems